Cellective BioTherapy Overview
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
Cellective BioTherapy General Information
Description
Developer of a biotechnology platform designed to enhance or inhibit immune responses. The company's platform provides the ability to expand human B cells for use as autologous cellular immunotherapy for treating cancers, autoimmunity, and immunodeficiency, enabling physicians to treat patients without destroying essential cells and their protective functions.
Contact Information
Website
www.cellectivebiotherapy.comCorporate Office
- 6 Davis Drive
- Research Triangle Park
- Durham, NC 27709
- United States
Corporate Office
- 6 Davis Drive
- Research Triangle Park
- Durham, NC 27709
- United States
Cellective BioTherapy Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Secondary Transaction - Private | 01-Jul-2023 | Completed | Pre-Clinical Trials | |||
5. Early Stage VC (Series A) | 26-May-2015 | Completed | Startup | |||
4. Accelerator/Incubator | Completed | Startup | ||||
3. Early Stage VC | Completed | Startup | ||||
2. Merger/Acquisition | Completed | Startup | ||||
1. University Spin-Out | 01-Jan-2015 | Completed | Startup |
Cellective BioTherapy Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
Cellective BioTherapy Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Eshelman Ventures | Venture Capital | Minority | ||
Sofinnova Investments | Venture Capital | Minority |
Cellective BioTherapy FAQs
-
Where is Cellective BioTherapy headquartered?
Cellective BioTherapy is headquartered in Durham, NC.
-
What industry is Cellective BioTherapy in?
Cellective BioTherapy’s primary industry is Drug Discovery.
-
Is Cellective BioTherapy a private or public company?
Cellective BioTherapy is a Private company.
-
What is Cellective BioTherapy’s current revenue?
The current revenue for Cellective BioTherapy is
. -
How much funding has Cellective BioTherapy raised over time?
Cellective BioTherapy has raised $2.5M.
-
Who are Cellective BioTherapy’s investors?
Eshelman Ventures and Sofinnova Investments have invested in Cellective BioTherapy.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »